Ability of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxins
-
Add time:09/25/2019 Source:sciencedirect.com
We examined the ability of wedelolactone, heparin and para-bromophenacyl bromide to antagonize the myotoxic activity in mice of venoms from Crotalus viridis viridis and Agkistrodon contortrix laticinctus and two phospholipase A2 myotoxins, CVV myotoxin and ACL myotoxin, isolated from them. Myotoxicity was measured by the increase in plasma creatine kinase (CK) activity at two hours and histological changes in extensor digitorum longus muscle (EDL) at three hours after injection of the test solution. Both heparin and wedelolactone independently reduced the myotoxic effect of both crude venoms and both myotoxins, but wedelolactone was more effective. Wedelolactone plus heparin reduced the myotoxic effect of CVV myotoxin more than either antagonist alone. The PLA2 inhibitor, para-bromophenacyl bromide (pBPB), reduced the myotoxic effect of both myotoxins more than either wedelolactone or heparin. On the other hand, the myotoxic effect of polylysine was not reduced by either wedelolactone or para-bromophenacyl bromide, but it was reduced by heparin. These results indicate that wedelolactone, para-bromophenacyl bromide and heparin are antagonists of these two phospholipase A2 myotoxins, and that antagonism by the first two compounds may be due to a more specific interaction with these proteins than that by the latter.
We also recommend Trading Suppliers and Manufacturers of 3-BROMOPHENACYL BROMIDE (cas 18523-22-3). Pls Click Website Link as below: cas 18523-22-3 suppliers
Prev:The disruption of brain microtubules in vitro by the phospholipase inhibitor p-bromophenacyl bromide
Next:Nitrile biotransformations for the practical synthesis of highly enantiopure azido carboxylic acids and amides, ‘click’ to functionalized chiral triazoles and chiral β-amino acids) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The disruption of brain microtubules in vitro by the phospholipase inhibitor p-bromophenacyl bromide09/24/2019
- Crystal structure of a phospholipase A2 homolog complexed with p-bromophenacyl bromide reveals important structural changes associated with the inhibition of myotoxic activity09/10/2019
- Short crystallization paperCrystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A2 complexed with p-bromophenacyl bromide and α-tocopherol inhibitors at 1.9- and 1.45-Å resolution09/09/2019
- The phospholipase A2 inhibitor bromophenacyl bromide prevents the depolarization-induced increase in [3HAMPA binding in rat brain synaptoneurosomes09/08/2019
- Synthesis and cytotoxic activity of novel 1-((indol-3-yl)methyl)–1H-imidazolium salts09/07/2019
- Short communicationp-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities09/06/2019
- 4-Bromophenacyl bromide induces Ca2+ influx in human gingival fibroblasts09/05/2019


